Filing Details
- Accession Number:
- 0001441557-17-000001
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-01-04 11:45:05
- Reporting Period:
- 2016-12-31
- Filing Date:
- 2017-01-04
- Accepted Time:
- 2017-01-04 11:45:05
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1187953 | Creative Medical Technology Holdings Inc. | CELZ | Biological Products, (No Disgnostic Substances) (2836) | 870622284 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1538398 | Creative Medical Health Inc. | 2007 W. Peoria Ave. Phoenix AZ 85029 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2016-12-31 | 2,935,609 | $0.10 | 62,061,059 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 64,996,667 | Direct |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Warrants | $0.10 | 2016-09-30 | 2026-09-30 | 30,000 | 30,000 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2026-09-30 | 30,000 | 30,000 | Direct |
Footnotes
- The transaction reported hereby represents a cancellation of debt owed by the reporting party to the purchaser. The total amount of debt exchanged for the common shares was $293,560.91, or $0.10 per share, the same price as shares of common stock purchased by the reporting party on September 30, 2016. As an incentive to enter into the transaction the reporting party granted to the purchaser an option to purchase up to 293,561 shares of the Issuer at $0.10 per share with such option expiring August 1, 2019.